Overview :
Dr. Paras Satadeve is an EHA-certified Hematologist with specialized expertise in Benign Hematology, Hemato-Oncology, and Bone Marrow Transplant (BMT).
He has served as a Senior Resident at prestigious institutions, including AIIMS Bhopal and Gandhi Medical College, gaining strong clinical experience in hematological disorders.
He has worked as an Associate Consultant at Yashoda Hospitals, Hyderabad, where he focused on advanced hematological care and bone marrow transplant procedures.
A dedicated researcher, he has served as a Principal Investigator in clinical trials focused on Chronic Myeloid Leukemia (CML) and has contributed to multiple international multi-center phase III studies.
Associate Consultant – Hemato-Oncology & Bone Marrow Transplant (BMT)
Marengo Asia Hospitals, Gurugram
Associate Consultant – Hematology & BMT
Yashoda Hospitals, Hyderabad
Senior Resident – Hematology / General Medicine
AIIMS Bhopal
Senior Resident – General Medicine
Gandhi Medical College, Bhopal
MBBS – 2015
MD (General Medicine) – Gandhi Medical College, Bhopal, Madhya Pradesh, India – 2020
DM (Clinical Hematology) – All India Institute of Medical Sciences (AIIMS), Rishikesh, India – 2025
European Hematology Association (EHA) Certified Hematologist – 2025
Benign HematologyHemato-Oncology
Bone Marrow Transplant (BMT)
Chronic Myeloid Leukemia (CML) Management
Clinical Trial Research
Lead Author of multiple randomized controlled studies evaluating the efficacy and safety of lower-dose versus standard-dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia (CML).
Published researcher in reputed international journals, including Blood, with a focus on real-world molecular responses in leukemia.
Authored case reports on rare cytogenetic abnormalities and leukemoid reactions in specialized hematology journals.
Presenter at major global conferences, including the European Hematology Association (EHA) Congress (Milan, Madrid) and Hematocon.
Life Member, Indian Society of Hematology and Blood Transfusion (ISHBT)
Member, European Hematology Association (EHA)
Member, European Society for Medical Oncology (ESMO)
Work Experience :
Associate Consultant – Hemato-Oncology & Bone Marrow Transplant (BMT)
Marengo Asia Hospitals, Gurugram
Associate Consultant – Hematology & BMT
Yashoda Hospitals, Hyderabad
Senior Resident – Hematology / General Medicine
AIIMS Bhopal
Senior Resident – General Medicine
Gandhi Medical College, Bhopal
Qualification :
MBBS – 2015
MD (General Medicine) – Gandhi Medical College, Bhopal, Madhya Pradesh, India – 2020
DM (Clinical Hematology) – All India Institute of Medical Sciences (AIIMS), Rishikesh, India – 2025
European Hematology Association (EHA) Certified Hematologist – 2025
Area Of Expertise :
Benign HematologyHemato-Oncology
Bone Marrow Transplant (BMT)
Chronic Myeloid Leukemia (CML) Management
Clinical Trial Research
Research & Publications :
Lead Author of multiple randomized controlled studies evaluating the efficacy and safety of lower-dose versus standard-dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia (CML).
Published researcher in reputed international journals, including Blood, with a focus on real-world molecular responses in leukemia.
Authored case reports on rare cytogenetic abnormalities and leukemoid reactions in specialized hematology journals.
Presenter at major global conferences, including the European Hematology Association (EHA) Congress (Milan, Madrid) and Hematocon.
Memberships :
Life Member, Indian Society of Hematology and Blood Transfusion (ISHBT)
Member, European Hematology Association (EHA)
Member, European Society for Medical Oncology (ESMO)
